Rammazzo Laura, Kikidis Dimitris, Anwer Amal, Macdonald Nora, Kyrodimos Efthymios, Maurer Christoph, Wuyts Floris, Luxon Linda, Bibas Athanasios, Bamiou Doris-Eva
Neuro-otology Department, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.
UCL Ear Institute, University College London, 332 Gray's Inn Road, London, WC1X 8EE, UK.
Trials. 2016 Sep 5;17(1):435. doi: 10.1186/s13063-016-1568-x.
Balance problems are caused by multiple factors and often lead to falls and related fractures, bringing large socio-economic costs. The complexity of balance control mechanisms, the lack of medical expertise, and the absence of specialised equipment contribute to the delayed or incorrect diagnosis and management ofthese patients. Advances in computer science have allowed the development of computer systems that support clinical diagnosis and treatment decisions based on individualised patient data. The aim of the EMBalance decision support system (DSS) is to support doctors facing this clinical challenge, to make a definitive diagnosis and implement an effective management plan. The EMBalance study will determine the accuracy of this supportive tool when used by non-specialist doctors. This study is funded by the European Union's Seventh Framework Programme.
METHODS/DESIGN: EMBalance is a proof-of-concept study designed as a non-commercial, international, multi-centre, single-blind, parallel-group randomised controlled trial to be carried out at four clinical sites in the United Kingdom, Germany, Greece and Belgium. The study is comprised of three stages: internal pilot, phase I (diagnosis) and stage II (management). For this purpose, 200 patients presenting with persistent dizziness (>3 months' duration) to primary care services will be randomised to either the intervention group (diagnostic assessment with the DSS) or a control group (diagnostic assessment without the DSS). Patients allocated to the intervention group will be assessed by a doctor with the support of the EMBalance DSS, while patients allocated to the control group will receive a visit as per standard practice. Ultimately, all patients' diagnoses and management plans will be certified by a consultant in neuro-otology.
EMBalance is the first trial to test the accuracy of a DSS in both the diagnosis of and the management plan for vestibular disorders across the healthcare systems of four different countries. The EMBalance study is the result of a combined effort of engineers and physicians to develop an accurate tool to support non-specialist doctors, with no risk for the patient. This trial will provide reliable information about the benefits of implementing DSSs in primary care while supporting the feasibility of testing the EMBalance algorithms in further research.
ClinicalTrials.gov NCT02704819 . Registered 29 February 2016.
平衡问题由多种因素引起,常导致跌倒及相关骨折,带来巨大的社会经济成本。平衡控制机制的复杂性、医学专业知识的欠缺以及专门设备的缺失,致使这些患者的诊断和管理出现延迟或错误。计算机科学的进步推动了基于个体化患者数据支持临床诊断和治疗决策的计算机系统的发展。EMBalance决策支持系统(DSS)的目的是为面临这一临床挑战的医生提供支持,以做出明确诊断并实施有效的管理计划。EMBalance研究将确定非专科医生使用这一支持工具时的准确性。本研究由欧盟第七框架计划资助。
方法/设计:EMBalance是一项概念验证研究,设计为非商业性、国际性、多中心、单盲、平行组随机对照试验,将在英国、德国、希腊和比利时的四个临床地点开展。该研究包括三个阶段:内部预试验、第一阶段(诊断)和第二阶段(管理)。为此,200名向初级保健服务机构就诊且有持续头晕(持续时间超过3个月)症状的患者将被随机分为干预组(使用DSS进行诊断评估)或对照组(不使用DSS进行诊断评估)。分配到干预组的患者将在EMBalance DSS的支持下由医生进行评估,而分配到对照组的患者将按照标准流程接受诊疗。最终,所有患者的诊断和管理计划将由神经耳科学顾问进行认证。
EMBalance是第一项测试DSS在四个不同国家医疗系统中对前庭疾病诊断及管理计划准确性的试验。EMBalance研究是工程师和医生共同努力的成果,旨在开发一种准确的工具来支持非专科医生,且对患者无风险。该试验将提供有关在初级保健中实施DSS的益处的可靠信息,同时支持在进一步研究中测试EMBalance算法的可行性。
ClinicalTrials.gov NCT02704819。2016年2月29日注册。